The main objective of this program is to expand our knowledge of the pathogenesis and treatment of schistosomiasis, leprosy and leishmaniasis. The Tropical Medicine Research Center will increase our collaboration with American scientists and provide opportunities for United States investigators to conduct research on tropical diseases. Major diseases which are endemic in the State of Bahia, brazil include: leishmaniasis, schistosomiasis, filariasis, Chagas' disease, leprosy, malaria and strongyloidiasis. The overall goals are to increase our understanding of host defense mechanisms against S. mansoni and leishmania and to improve methods for the treatment of leishmaniasis and leprosy. Project 1, Host Immune Response in Schistosomiasis will identify factors contributing to host resistance to reinfection.
The specific aim i s to correlate cellular immune responses with susceptibility to S. mansoni infection and to identify antigens that are involved in immuno protection. Project 2, T Cell responses in Human Leishmaniasis will examine T cell responses and the role of cytotoxic cells in the control of leishmania infection and histological aspects of cutaneous, mucosal and visceral leishmania infection and histological aspects of cutaneous, mucosal and visceral leishmaniasis. Project 3, Immunotherapy of Leprosy and Leishmaniasis will evaluate therapy with gamma interferon in combination with conventional therapy in patients with diffuse and cutaneous leishmaniasis and leprosy. Patients with leishmaniasis and schistosomiasis will be recruited from endemic areas located within the State of Bahia, Brazil.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
5P50AI030639-04
Application #
2065805
Study Section
Special Emphasis Panel (SRC (55))
Project Start
1991-03-01
Project End
1996-02-29
Budget Start
1994-03-01
Budget End
1995-02-28
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Federal University of Bahia
Department
Type
DUNS #
900845397
City
Salvador
State
Country
Brazil
Zip Code
40110-160
Sousa, Rosana; Andrade, Viviane M; Bair, Thomas et al. (2018) Early Suppression of Macrophage Gene Expression by Leishmania braziliensis. Front Microbiol 9:2464
Silva, Silvana C; Guimarães, Luiz Henrique; Silva, Juliana A et al. (2018) Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients. Acta Trop 178:34-39
Teixeira, D G; Monteiro, G R G; Martins, D R A et al. (2017) Comparative analyses of whole genome sequences of Leishmania infantum isolates from humans and dogs in northeastern Brazil. Int J Parasitol 47:655-665
Lima, Josivan Gomes; Nobrega, Lucia Helena C; Lima, Natalia Nobrega et al. (2017) Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy. Bone 101:21-25
Lima, Ádila L M; de Lima, Iraci D; Coutinho, José F V et al. (2017) Changing epidemiology of visceral leishmaniasis in northeastern Brazil: a 25-year follow-up of an urban outbreak. Trans R Soc Trop Med Hyg 111:440-447
Kelly, Patrick H; Bahr, Sarah M; Serafim, Tiago D et al. (2017) The Gut Microbiome of the Vector Lutzomyia longipalpis Is Essential for Survival of Leishmania infantum. MBio 8:
Gimblet, Ciara; Meisel, Jacquelyn S; Loesche, Michael A et al. (2017) Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation. Cell Host Microbe 22:13-24.e4
Almeida, Lucas; Silva, Juliana A; Andrade, Viviane M et al. (2017) Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection. Infect Genet Evol 49:212-220
Weirather, Jason L; Duggal, Priya; Nascimento, Eliana L et al. (2017) Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil. Ann Hum Genet 81:41-48
Novais, Fernanda O; Carvalho, Augusto M; Clark, Megan L et al. (2017) CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1? production. PLoS Pathog 13:e1006196

Showing the most recent 10 out of 85 publications